Advertisement

Estrella Immunopharma, Inc. ESLA

Set alert

Price alert · ESLA

All alert types
0.43 USD -0.21 -33.51%

As of Nov 2, 3:21 PM ET

Bid
0.42 × 1
Ask
0.43 × 1
0.425 Day range 0.6393
0.24 52-week range 3.15
YTD
-72.75%
1 year
-82.43%
Open
0.611
Prev close
0.6393
Mkt cap
18.49M
Vol
557.91K
Avg vol
1.78M
EPS
-0.25
P/E
0.00
Div yield
0.00%
More statistics
Low
0.425
High
0.6393
Forward P/E
0.00
Beta
0.24
Short ratio
0.07
Inst. own
0.55%
Dividend
0.00
Ex-div date
50-d avg
0.97534
200-d avg
1.10
1y target
0.00

1D chart

Chart tools
Interval

Signals (103)
NameTimeAgo
MACD: Sell Signal3:10 PM12 minutes ago
RSI: Oversold3:10 PM12 minutes ago
MACD: Buy Signal3:05 PM17 minutes ago
RSI: Oversold3:01 PM21 minutes ago
MACD: Sell Signal2:54 PM28 minutes ago
RSI: Oversold2:54 PM28 minutes ago
MACD: Buy Signal2:41 PM41 minutes ago
MACD: Sell Signal2:26 PM56 minutes ago
SMA: Bearish2:18 PM1 hour ago
SMA: Bearish2:18 PM1 hour ago
SMA: Bullish2:17 PM1 hour ago
SMA: Bullish2:17 PM1 hour ago
RSI: Overbought2:17 PM1 hour ago
MACD: Buy Signal2:12 PM1 hour ago
SMA: Bearish1:57 PM1 hour ago
SMA: Bearish1:57 PM1 hour ago
RSI: Oversold1:57 PM1 hour ago
MACD: Sell Signal1:46 PM1 hour ago
SMA: Bullish1:32 PM1 hour ago
SMA: Bullish1:32 PM1 hour ago
MACD: Buy Signal1:32 PM1 hour ago
SMA: Bearish1:27 PM1 hour ago
MACD: Sell Signal1:27 PM1 hour ago
SMA: Bullish1:23 PM1 hour ago
SMA: Bearish1:20 PM2 hours ago
SMA: Bearish1:18 PM2 hours ago
SMA: Bullish1:17 PM2 hours ago
SMA: Bullish1:14 PM2 hours ago
MACD: Buy Signal1:03 PM2 hours ago
MACD: Sell Signal12:58 PM2 hours ago
SMA: Bearish12:57 PM2 hours ago
SMA: Bearish12:57 PM2 hours ago
SMA: Bullish12:56 PM2 hours ago
SMA: Bullish12:56 PM2 hours ago
SMA: Bearish12:54 PM2 hours ago
SMA: Bearish12:54 PM2 hours ago
SMA: Bullish12:53 PM2 hours ago
SMA: Bullish12:53 PM2 hours ago
MACD: Buy Signal12:53 PM2 hours ago
MACD: Sell Signal12:46 PM2 hours ago
RSI: Oversold12:46 PM2 hours ago
MACD: Buy Signal12:45 PM2 hours ago
MACD: Sell Signal12:25 PM2 hours ago
SMA: Bearish12:24 PM2 hours ago
SMA: Bearish12:24 PM2 hours ago
RSI: Overbought12:13 PM3 hours ago
SMA: Bullish12:12 PM3 hours ago
SMA: Bullish12:11 PM3 hours ago
MACD: Buy Signal12:11 PM3 hours ago
SMA: Bearish12:10 PM3 hours ago
MACD: Sell Signal12:10 PM3 hours ago
SMA: Bullish12:09 PM3 hours ago
MACD: Buy Signal12:09 PM3 hours ago
MACD: Sell Signal12:05 PM3 hours ago
RSI: Oversold12:05 PM3 hours ago
MACD: Buy Signal12:04 PM3 hours ago
RSI: Oversold11:53 AM3 hours ago
SMA: Bearish11:44 AM3 hours ago
MACD: Sell Signal11:44 AM3 hours ago
SMA: Bullish11:30 AM3 hours ago
SMA: Bearish11:29 AM3 hours ago
SMA: Bearish11:29 AM3 hours ago
SMA: Bullish11:27 AM3 hours ago
SMA: Bullish11:26 AM3 hours ago
MACD: Buy Signal11:26 AM3 hours ago
MACD: Sell Signal11:21 AM4 hours ago
SMA: Bearish11:16 AM4 hours ago
SMA: Bearish11:16 AM4 hours ago
SMA: Bullish11:15 AM4 hours ago
SMA: Bullish11:15 AM4 hours ago
MACD: Buy Signal11:12 AM4 hours ago
SMA: Bearish11:01 AM4 hours ago
SMA: Bearish11:01 AM4 hours ago
MACD: Sell Signal11:01 AM4 hours ago
SMA: Bullish11:00 AM4 hours ago
SMA: Bullish11:00 AM4 hours ago
MACD: Buy Signal11:00 AM4 hours ago
SMA: Bearish10:57 AM4 hours ago
SMA: Bearish10:57 AM4 hours ago
MACD: Sell Signal10:57 AM4 hours ago
SMA: Bullish10:56 AM4 hours ago
SMA: Bullish10:56 AM4 hours ago
MACD: Buy Signal10:56 AM4 hours ago
SMA: Bearish10:53 AM4 hours ago
SMA: Bearish10:53 AM4 hours ago
MACD: Sell Signal10:53 AM4 hours ago
SMA: Bullish10:52 AM4 hours ago
SMA: Bullish10:51 AM4 hours ago
SMA: Bearish10:50 AM4 hours ago
SMA: Bearish10:50 AM4 hours ago
SMA: Bullish10:48 AM4 hours ago
SMA: Bullish10:48 AM4 hours ago
SMA: Bearish10:47 AM4 hours ago
SMA: Bearish10:47 AM4 hours ago
SMA: Bullish10:43 AM4 hours ago
SMA: Bullish10:42 AM4 hours ago
SMA: Bearish10:36 AM4 hours ago
SMA: Bullish10:35 AM4 hours ago
MACD: Buy Signal10:28 AM4 hours ago
RSI: Oversold10:24 AM4 hours ago
MACD: Sell Signal10:22 AM5 hours ago
RSI: Oversold10:20 AM5 hours ago
RSI: Oversold10:04 AM5 hours ago

Key statistics

Market cap
40.88M
Enterprise value
28.05M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
9.58
EPS (TTM)
-0.24
Beta
0.24
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-12.95M
Total cash
4.17M
Total debt
4.00K
Return on equity
0.00%
Shares outstanding
36.18M
Short % of float
0.06%
50-day average
0.97534
200-day average
1.10

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
ESLA Revenue — quarterly 0
2023-Q1 20222022-Q4 20222023-Q1 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252025-Q4 20252026-Q1 20262026-Q2 2026
ESLA Net income — quarterly -2.31M
2023-Q1 20222022-Q4 20222023-Q1 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252025-Q4 20252026-Q1 20262026-Q2 2026
ESLA EPS — quarterly -0.05
2023-Q1 20222022-Q4 20222023-Q1 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252025-Q4 20252026-Q1 20262026-Q2 2026

About Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on ESLA — it syncs with the Stock Master app.

Institution ownership

ESLA institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.21%76,55686.51KSep 29, 2024
ATW Spac Management LLC0.11%40,00045.20KSep 29, 2024
Blackrock Inc.0.07%24,96328.21KSep 29, 2024
Vanguard Group Inc0.06%21,68424.50KSep 29, 2024
Citadel Advisors Llc0.04%14,53116.42KSep 29, 2024
Maso Capital Partners Ltd.0.03%10,00011.30KSep 29, 2024

Fund ownership

ESLA fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.16%56,77964.16KOct 30, 2024
iShares Micro Cap ETF0.06%22,43525.35KOct 30, 2024
Vanguard Total Stock Market Index Fund0.05%17,96820.30KSep 29, 2024
Fidelity Total Market Index Fund0.05%16,86219.05KOct 30, 2024
Fidelity Series Total Market Index Fund0.04%13,41315.16KOct 30, 2024
EQ Advisors Trust-1290 VT Micro Cap Port0.01%2,3732.68KSep 29, 2024
Advertisement